Skip to main content
Clinical Trials/NCT03853252
NCT03853252
Completed
Not Applicable

iPS Cells of Patients for Models of Retinal Dystrophies

University Hospital, Montpellier1 site in 1 country150 target enrollmentNovember 3, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinal Dystrophies
Sponsor
University Hospital, Montpellier
Enrollment
150
Locations
1
Primary Endpoint
number of human cell models obtained
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

The investigators are focused on inherited retinal dystrophies with an aim to further understand disease pathophysiology and to elaborate novel treatments, as, to date, there is no effective treatment to prevent blindness.

The main goal of this study is to generate human cellular models of healthy and disease retinas and perform studies to evaluate the efficiency of gene therapy approaches for different diseases.

Skin biopsies of volunteers are cultured to isolate fibroblasts that are then reprogrammed into iPS cells. Healthy and disease-specific iPS cells are then differentiated into retinal models.

This study should help to elucidate disease pathways and to provide proof-of-concept for various therapeutic approaches.

Registry
clinicaltrials.gov
Start Date
November 3, 2014
End Date
October 30, 2023
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

number of human cell models obtained

Time Frame: 10 years

Study Sites (1)

Loading locations...

Similar Trials